Agios Pharmaceuticals Inc (NASDAQ:AGIO)

95.78
Delayed Data
As of 10:19am ET
 +1.15 / +1.22%
Today’s Change
31.51
Today|||52-Week Range
138.85
-14.51%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Celgene Corp
Buy12/16/2014228,645$110.75$25.3M-11.95%
Biller Scott
Chief Scientific Officer
Sale9/19/201437,996$50.45$1.9M+93.48%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+48.42%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+48.42%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale2/09/201515,000$105.81$1.6M-10.69%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M-13.78%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M-13.78%
Higgons John Duncan
Chief Operating Officer
Sale12/01/201412,000$97.03$1.2M-1.70%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale3/16/201510,000$106.24$1.1M-11.10%
Higgons John Duncan
Chief Operating Officer
Sale11/03/201413,000$81.71$1.1M+13.92%
Page of 12

To view my watchlist

Not a member yet?

Sign up now for a free account